B-CELL LEUKEMIA
Clinical trials for B-CELL LEUKEMIA explained in plain language.
Never miss a new study
Get alerted when new B-CELL LEUKEMIA trials appear
Sign up with your email to follow new studies for B-CELL LEUKEMIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New CAR-T therapy CLIC-2201 enters human trials for Hard-to-Treat blood cancers
Disease control Recruiting nowThis early-phase trial tests a new treatment called CLIC-2201 for people with B-cell blood cancers that have come back or not responded to standard therapy. CLIC-2201 is made from a patient's own immune cells, which are modified in a lab to better recognize and attack cancer cell…
Matched conditions: B-CELL LEUKEMIA
Phase: PHASE1 • Sponsor: British Columbia Cancer Agency • Aim: Disease control
Last updated May 17, 2026 01:29 UTC
-
New CAR-T therapy targets stubborn leukemia cells that evade standard treatment
Disease control Recruiting nowThis study tests a new type of CAR-T cell therapy for people with B-cell leukemia whose cancer cells do not have the CD19 protein or have stopped responding to standard CD19-targeted CAR-T. The treatment uses immune cells engineered to recognize several other markers on leukemia …
Matched conditions: B-CELL LEUKEMIA
Phase: PHASE1, PHASE2 • Sponsor: Shenzhen Geno-Immune Medical Institute • Aim: Disease control
Last updated May 14, 2026 12:02 UTC
-
New Dual-Target CAR T-Cell therapy offers hope for relapsed childhood leukemia
Disease control Recruiting nowThis study tests a new type of immunotherapy for children and young adults (ages 3-39) with B-cell cancers like leukemia or lymphoma that have come back or not responded to standard treatments. The therapy uses the patient's own immune cells, which are modified in a lab to target…
Matched conditions: B-CELL LEUKEMIA
Phase: PHASE1, PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 13, 2026 15:58 UTC
-
Study seeks to solve vaccine puzzle for kids treated for blood cancer
Knowledge-focused Recruiting nowThis study looks at whether children and young adults (up to age 21) who received blinatumomab for B-cell acute lymphoblastic leukemia still have protection from their childhood vaccines. Researchers will test antibody levels for diseases like tetanus, hepatitis B, and measles. I…
Matched conditions: B-CELL LEUKEMIA
Sponsor: Arkansas Children's Hospital Research Institute • Aim: Knowledge-focused
Last updated May 11, 2026 20:54 UTC